Astropharmacology — Part I —

Reblog: Originally Posted on August 11, 2014 — 4th post since the creation of this blog (August 10, 2014) —

Astropharmacology: name proposal for a scientific field devoted to understand why the names of magnificent planets are used as acronyms of poor quality clinical trials.

Part 1: Neptune and Saturn —

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (NEPTUNE)Neptune_Full (1)

Why I think the overall quality of this study is poor? PubMed Commons comment on NEPTUNE


A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH (SATURN)

Saturn_PIA06077

Why I think the overall quality of this study is poor? PubMed Commons comments on SATURN


What will be discussed in part 2?

Jupiter_by_Cassini-Huygens
The gravity of Jupiter is inversely proportional to the quality of their homonymous clinical trial


 A message to pharmaceutical companies
Think twice before choosing the name of a planet as an acronym for your next clinical trial.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: